Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-19

FDA Approved: MOXIFLOXACIN OPHTHALMIC SOLUTION — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's supplemental application for moxifloxacin ophthalmic solution. This approval concerns the generic ophthalmic anti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin ophthalmic solution (moxifloxacin)

Snippet

SUPPL AP for MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN OPHTHALMIC SOLUTION)